Form 4: Phillip Frost, OPKO Health CEO, Acquires 600,000 Shares
SEC Form 4 Filing
OPKO Health's CEO, Phillip Frost, and related entities, acquired 600,000 shares of common stock at an average price of $0.9323 on March 12, 2024.
Summary
- Phillip Frost, the CEO and Chairman of OPKO Health, along with Frost Gamma Investments Trust, filed a Form 4 detailing changes in beneficial ownership.
- On March 12, 2024, Dr. Frost purchased 600,000 shares of OPKO Health common stock at a weighted average price of $0.9323 per share, with prices ranging from $0.9213 to $0.9398.
- Following the transaction, Dr. Frost directly owns 3,068,951 shares.
- Dr. Frost also has indirect ownership through Frost Gamma Investments Trust (209,468,225 shares) and Frost Nevada Investments Trust (30,127,177 shares).
- Dr. Frost disclaims beneficial ownership of shares held by Frost Gamma Investments Trust and Frost Nevada Investments Trust except to the extent of any pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase is a positive signal, but it's a routine filing and doesn't contain any groundbreaking news.
Positives
- The CEO's purchase of a significant number of shares could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive signal, suggesting that a company's leadership believes the stock is undervalued. However, it's important to consider the overall context of the company's performance and industry trends.
Comparison to Industry Standards
- It's difficult to compare this specific transaction to industry standards without knowing the typical insider trading activity within the biotechnology sector.
- However, large purchases by CEOs are generally viewed favorably by investors.
- Comparisons could be made to similar insider transactions at companies like Amgen, Gilead Sciences, or Biogen to gauge the relative significance of this purchase.
Stakeholder Impact
- The CEO's share purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/12/2024 | Date of the transaction: Phillip Frost purchased 600,000 shares of OPKO Health common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.